News
05-02-2013, 10:50 PM
A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment.
More... (http://www.news-medical.net/news/20130503/New-findings-to-benefit-women-with-oestrogen-receptor-positive-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20130503/New-findings-to-benefit-women-with-oestrogen-receptor-positive-breast-cancer.aspx)